How to avoid getting crushed by falling ASX growth shares

What happens to the share price when the growth story stops? We just need to look at Gentrack Group Ltd (ASX: GTK), Nearmap Ltd (ASX: NEA) and WiseTech Global Ltd (ASX: WTC).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In space, when a giant star runs out of the gas that fuels it, it will collapse spectacularly in on itself. The collapse creates a crushing gravitational pull from which nothing, not even light, can escape. Hence its name; a black hole.

When a company with a popular growth story runs out of gas, the same thing can happen. The investor expectations that fuel the glowing share price run dry and the implosion that follows can wipe out years of gains.

In more than 10 years of investing I have never seen this to be as dramatic as in the last 12 months. In my view, a lot of ASX growth shares have high expectations, higher valuations and there seems to be little consideration for margin of safety.

Even before the February reporting season took off we saw large share price falls as companies with strong expectations like Gentrack Group Ltd (ASX: GTK) and Nearmap Ltd (ASX: NEA) revised guidance down. As reporting season gathers pace, other stars have also imploded.

Last week, investors in WiseTech Global Ltd (ASX: WTC) rudely discovered the strong expectations for growth were over-done. Share price declines in Citadel Group Ltd (ASX: CGL) and the cooling-off of Altium Limited (ASX: ALU) and EML Payments Ltd (ASX: EML) are further examples.

Most of these are great businesses which in years to come will continue to grow steadily. But the huge demand for companies with growth narratives and high valuations means it's time to be extra vigilant.

a woman

How to avoid getting crushed

As investors, our job is to evaluate the narrative around a company and decide 1) if it is reasonable and 2) if the share price reflects this. It is not easy, but it is essential if we are to avoid getting crushed.

For a long time, the management team of utility billing software company Gentrack was telling a story of "15%+ long‐term organic EBITDA growth", caveated with the specific timing of projects. It appeared realistic and the share price rose along with investor expectations.

I certainly believed it. But I should have been more skeptical when the chief operating officer suddenly departed and the company started machine-gunning warnings to the market that growth was in doubt.

Foolish takeaway

To safely navigate the pull of star ASX shares, don't be afraid to stay skeptical and stay diversified. It can be exciting to find a company with great growth prospects, but having a sense of valuation is critical to prevent your money from being lost into the investing void.

Motley Fool contributor Regan Pearson owns shares of GENTRACK FPO NZ.

You can follow him on Twitter @Regan_Invests.

The Motley Fool Australia owns shares of and has recommended Emerchants Limited and Nearmap Ltd. The Motley Fool Australia owns shares of Altium and WiseTech Global. The Motley Fool Australia has recommended Citadel Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These valuations are too good to ignore! I'd buy these ASX shares today

I think these businesses have very attractive futures.

Read more »

A man and woman jump in the air and high five with both hands on a road after running.
Growth Shares

2 battered ASX growth shares that could double in value or more

Brokers are strikingly bullish and tip up to 180% upside.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 top ASX shares I'd buy right now in this March madness

The valuations these businesses are now trading at are too good to ignore!

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

3 undervalued ASX stocks to consider buying immediately

Analysts are tipping huge upsides ahead for these undervalued shares.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 ASX growth stocks down 40% to 60% to buy now

Big sell-offs can sometimes create compelling investment opportunities.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Growth Shares

Brokers rate these 2 top ASX shares as buys in March

Here’s why experts are confident about these businesses for the long-term.

Read more »